179 related articles for article (PubMed ID: 28974598)
1. Molecular radiotheragnostics in thyroid disease.
Singh N; Lewington V
Clin Med (Lond); 2017 Oct; 17(5):453-457. PubMed ID: 28974598
[TBL] [Abstract][Full Text] [Related]
2. Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy.
Meller J; Becker W
Q J Nucl Med; 1999 Sep; 43(3):179-87. PubMed ID: 10568133
[TBL] [Abstract][Full Text] [Related]
3. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound.
Meller J; Becker W
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S425-38. PubMed ID: 12192542
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo.
Schipper ML; Riese CGU; Seitz S; Weber A; Béhé M; Schurrat T; Schramm N; Keil B; Alfke H; Behr TM
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):638-650. PubMed ID: 17160413
[TBL] [Abstract][Full Text] [Related]
6. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
7. Sodium iodide symporter: its role in nuclear medicine.
Chung JK
J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
[TBL] [Abstract][Full Text] [Related]
8. Salivary gland scintigraphy after radioiodine therapy.
Malpani BL; Samuel AM; Jaiswar RK
Nucl Med Commun; 1998 Feb; 19(2):183-4. PubMed ID: 9548203
[No Abstract] [Full Text] [Related]
9. [Sodium/iodide symporter: physiopathological aspects and therapeutic perspectives].
Plantin-Carrenard E; Foglietti MJ; Beaudeux JL
Pathol Biol (Paris); 2005 Apr; 53(3):174-82. PubMed ID: 15781380
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
[TBL] [Abstract][Full Text] [Related]
11. [Nuclear medicine of the thyroid and parathyroid glands].
Ikekubo K
Kaku Igaku; 2001 Nov; 38(6):669-80. PubMed ID: 11806077
[TBL] [Abstract][Full Text] [Related]
12. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue.
Upadhyay G; Singh R; Agarwal G; Mishra SK; Pal L; Pradhan PK; Das BK; Godbole MM
Breast Cancer Res Treat; 2003 Jan; 77(2):157-65. PubMed ID: 12602914
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the sodium/iodide symporter explains 131I-induced thyroid stunning.
Nordén MM; Larsson F; Tedelind S; Carlsson T; Lundh C; Forssell-Aronsson E; Nilsson M
Cancer Res; 2007 Aug; 67(15):7512-7. PubMed ID: 17671222
[TBL] [Abstract][Full Text] [Related]
15. Reinforcing the Ability of 99mTcO4 Scintigraphy for Identifying Differentiated Thyroid Cancer by TSH Stimulation.
Ahn BC
Clin Nucl Med; 2016 Sep; 41(9):e412-3. PubMed ID: 27405037
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate.
Meller J; Wisheu S; Munzel U; Behe M; Gratz S; Becker W
Eur J Nucl Med; 2000 Sep; 27(9):1286-91. PubMed ID: 11007508
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of toxicological hazards from medical radioiodine administration.
Van Dyke M; Punja M; Hall MJ; Kazzi Z
J Med Toxicol; 2015 Mar; 11(1):96-101. PubMed ID: 25008160
[No Abstract] [Full Text] [Related]
18. Thyroid Cancer Radiotheragnostics: the case for activity adjusted
Avram AM; Dewaraja YK
Clin Transl Imaging; 2018 Oct; 6(5):335-346. PubMed ID: 30911535
[TBL] [Abstract][Full Text] [Related]
19. Nuclear medicine of the thyroid gland. Scintigraphy and radioiodine therapy.
Kintzer PP; Peterson ME
Vet Clin North Am Small Anim Pract; 1994 May; 24(3):587-605. PubMed ID: 8053114
[TBL] [Abstract][Full Text] [Related]
20. Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: initial feasibility study.
Jeong SY; Hwang MH; Kim JE; Kang S; Park JC; Yoo J; Ha JH; Lee SW; Ahn BC; Lee J
Endocr J; 2011; 58(7):575-83. PubMed ID: 21551958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
